Koenecke Ch

43PUBLICATIONS
225CO-AUTHORS
Gene and molecular therapyEpidemiological methodsCardiology (incl. cardiovascular diseases)Haematological tumoursTransplantation immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (43)

|Mar 28, 2026
Correction: Pourroy et al. High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European Registry. <i>Cancers</i> 2026, <i>18</i>, 124.

Bertrand Pourroy, Maria D Aumente, Christian Koenecke

|Jan 10, 2026
High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European Registry.

Bertrand Pourroy, Maria D Aumente, Christian Koenecke

|Aug 19, 2025
Chronic Graft-versus-Host disease trends over 30 years - a study by the EBMT transplant complications working party.

Drazen Pulanic, Christophe Peczynski, William Boreland

|Dec 11, 2024
Safety and efficacy of glofitamab for relapsed/refractory large B-cell lymphoma in a multinational real-world study.

Evgenii Shumilov, Rebecca Wurm-Kuczera, Andrea Kerkhoff

|Nov 20, 2024
Graft-versus-host disease after anti-CD19 chimeric antigen receptor T-cell therapy following allogeneic hematopoietic cell transplantation: a transplant complications and paediatric diseases working parties joint EBMT study.

Guillermo Ortí, Christophe Peczynski, William Boreland

|Oct 18, 2024
Correction: ECP versus ruxolitinib in steroid-refractory chronic GVHD - a retrospective study by the EBMT transplant complications working party.

Olaf Penack, Christophe Peczynski, William Boreland

Pageof 8

Frequent Collaborators

14 joint publications

Hélène Schoemans

14 joint publications

Olaf Penack

12 joint publications

Grzegorz W Basak

10 joint publications

Christophe Peczynski